ArticleDrug safety2025

Investigating Risk of Cancer with Sodium-Glucose Cotransporter 2 Inhibitors: A Disproportionality Analysis in the WHO Global Pharmacovigilance Database Vigibase

Paul Gautier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.